Stanley Plotkin of the Perelman School of Medicine weighed in on proposals to use a human challenge trial to fast-track a coronavirus vaccine. “If problems don’t arise along the way, I think it would be reasonable to hope that one could do a human challenge trial in about four months,” he said.

May 11, 2020 ・ From The Wall Street Journal